Preliminary experiences with sentinel lymph node detection in cases of vulvar malignancy

Area of Science:

• Oncology
• Nuclear Medicine
• Surgical Pathology

Background:

• Lymph node status is a critical prognostic indicator in vulvar malignancy.
• Accurate staging of vulvar neoplasms is essential for effective patient management.
• Sentinel lymph node biopsy is a key component in the surgical treatment of vulvar cancer.

Purpose of the Study:

• To evaluate the clinical significance and reliability of radionuclide lymphoscintigraphy for sentinel lymph node detection in patients with vulvar malignancy.
• To assess the feasibility of using technetium-99m nanocolloid for sentinel lymph node identification in vulvar cancer surgery.

Main Methods:

• A pilot study involving ten patients with vulvar neoplasms (squamous cell carcinoma and malignant melanoma).
• Administration of 100 MBq technetium-99m nanocolloid (Sentiscint) intravenously 24 hours prior to surgery.
• Sentinel lymph node localization using a gamma camera-computer system, followed by surgical removal and histological examination.

Main Results:

• Sentinel lymph node identification was successful in all ten patients.
• Three patients (30%) had positive sentinel lymph nodes, indicating micrometastasis.
• Postoperative follow-up revealed recurrence in two of the three patients with positive sentinel nodes.

Conclusions:

• Radionuclide lymphoscintigraphy is an easy and reliable method for sentinel lymph node detection in vulvar malignancy.
• This technique aids in the accurate staging and management of vulvar neoplasms.
• Early detection of lymph node involvement through sentinel lymphoscintigraphy can potentially improve patient outcomes.